NGL Fine Chem Ltd | a Momentum pharma stock
NGL Fine Chem Ltd | a Momentum pharma stock
Established in 1981, NGL Fine-Chem Limited manufacturers and markets APIs, Intermediates and Finished Dosage forms for human and animal pharmaceutical product. It caters to various Indian and global companies with high quality and reliable products.
Financial:
Market Cap = 1,382 Cr. ROCE = 11.5 % ROE = 9.31 %
Debt to equity = 0.11 Promoter holding = 73.1 % Piotroski score = 4.00
Quick ratio = 2.06 Current ratio = 2.58 Return on assets = 7.11 %
Profit Var 3Yrs = 18.5 % Sales growth 3Years = 21.8 % Pledged percentage = 0.00 %
in Technically you can see monthly and weekly strong RSI Momentum
financially also debt free company as well as company has good capex plan in comming years
so this will be next multibagger if hold for long time.
Note: I am not SEBI registered financial Adviser. I solely present my views on chart .I do not charge any kind of service. This is not buy sell recommendation.
If you like my ideas than like ,boost and follow me for more ideas.
Thanks and comment freely
Established in 1981, NGL Fine-Chem Limited manufacturers and markets APIs, Intermediates and Finished Dosage forms for human and animal pharmaceutical product. It caters to various Indian and global companies with high quality and reliable products.
Financial:
Market Cap = 1,382 Cr. ROCE = 11.5 % ROE = 9.31 %
Debt to equity = 0.11 Promoter holding = 73.1 % Piotroski score = 4.00
Quick ratio = 2.06 Current ratio = 2.58 Return on assets = 7.11 %
Profit Var 3Yrs = 18.5 % Sales growth 3Years = 21.8 % Pledged percentage = 0.00 %
in Technically you can see monthly and weekly strong RSI Momentum
financially also debt free company as well as company has good capex plan in comming years
so this will be next multibagger if hold for long time.
Note: I am not SEBI registered financial Adviser. I solely present my views on chart .I do not charge any kind of service. This is not buy sell recommendation.
If you like my ideas than like ,boost and follow me for more ideas.
Thanks and comment freely
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.